Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment

Forskningsoutput: TidskriftsbidragÖversiktsartikelVetenskapligPeer review

Originalspråkengelska
TidskriftActa Oncologica
Volym55
Utgåva9-10
Sidor (från-till)1069-1076
Antal sidor8
ISSN0284-186X
DOI
StatusPublicerad - 2016
MoE-publikationstypA2 Granska artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här

@article{5d8dcfe97013421898bfcb9dfaa65076,
title = "Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment",
keywords = "RECEPTOR RADIONUCLIDE THERAPY, NEUROENDOCRINE TUMORS, INDIVIDUALIZED DOSIMETRY, FOLLOW-UP, OCTREOTATE, PATIENT, LU-177-DOTATATE, GUIDELINES, DIAGNOSIS, TOXICITY, 3122 Cancers",
author = "Jorma Heikkonen and Hanna M{\"a}enp{\"a}{\"a} and Eero Hippel{\"a}inen and Vappu Reijonen and Mikko Tenhunen",
year = "2016",
doi = "10.1080/0284186X.2016.1182642",
language = "English",
volume = "55",
pages = "1069--1076",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "TAYLOR & FRANCIS LTD",
number = "9-10",

}

Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment. / Heikkonen, Jorma ; Mäenpää, Hanna; Hippeläinen, Eero ; Reijonen, Vappu; Tenhunen, Mikko.

I: Acta Oncologica, Vol. 55, Nr. 9-10, 2016, s. 1069-1076.

Forskningsoutput: TidskriftsbidragÖversiktsartikelVetenskapligPeer review

TY - JOUR

T1 - Effect of calculation method on kidney dosimetry in Lu-177-octreotate treatment

AU - Heikkonen, Jorma

AU - Mäenpää, Hanna

AU - Hippeläinen, Eero

AU - Reijonen, Vappu

AU - Tenhunen, Mikko

PY - 2016

Y1 - 2016

KW - RECEPTOR RADIONUCLIDE THERAPY

KW - NEUROENDOCRINE TUMORS

KW - INDIVIDUALIZED DOSIMETRY

KW - FOLLOW-UP

KW - OCTREOTATE

KW - PATIENT

KW - LU-177-DOTATATE

KW - GUIDELINES

KW - DIAGNOSIS

KW - TOXICITY

KW - 3122 Cancers

U2 - 10.1080/0284186X.2016.1182642

DO - 10.1080/0284186X.2016.1182642

M3 - Review Article

VL - 55

SP - 1069

EP - 1076

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 9-10

ER -